Which statement best distinguishes Type 1 diabetes mellitus from Type 2 diabetes mellitus in pathophysiology?

Which statement best distinguishes Type 1 diabetes mellitus from Type 2 diabetes mellitus in pathophysiology?

• A. Type 1 is autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency, often younger individuals.
• B. Type 1 is characterized by insulin resistance with obesity and a gradual onset.
• C. Type 1 typically presents with hyperinsulinemia and weight gain.
• D. Type 1 is primarily a result of excessive glucagon production without insulin deficiency.

Answer: (A)

The main distinction is that Type 1 diabetes is driven by autoimmune destruction of pancreatic beta cells, leading to an absolute lack of endogenous insulin. This often occurs in younger individuals and means patients require exogenous insulin because their pancreas can no longer produce insulin at all. In contrast, Type 2 diabetes centers on insulin resistance with a gradual decline in insulin secretion that is usually relative—patients produce insulin but not adequately to overcome the resistance, and this is commonly associated with obesity and occurs later in life. The statement that best distinguishes Type 1 from Type 2 is the description of autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency, often presenting in younger individuals. The other statements describe features more typical of Type 2 (insulin resistance with obesity; hyperinsulinemia and weight gain) or misstate the primary issue (glucagon dominance without insulin deficiency is not the defining pathophysiology of Type 1).

The main distinction is that Type 1 diabetes is driven by autoimmune destruction of pancreatic beta cells, leading to an absolute lack of endogenous insulin. This often occurs in younger individuals and means patients require exogenous insulin because their pancreas can no longer produce insulin at all. In contrast, Type 2 diabetes centers on insulin resistance with a gradual decline in insulin secretion that is usually relative—patients produce insulin but not adequately to overcome the resistance, and this is commonly associated with obesity and occurs later in life.

The statement that best distinguishes Type 1 from Type 2 is the description of autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency, often presenting in younger individuals. The other statements describe features more typical of Type 2 (insulin resistance with obesity; hyperinsulinemia and weight gain) or misstate the primary issue (glucagon dominance without insulin deficiency is not the defining pathophysiology of Type 1).